Ingmar Bruns - Chief Medical Officer at Zentalis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Issuer Symbol
ZNTL on Nasdaq
All Insider Reports
All Insider Reports

Ingmar Bruns - trading volume in the past year for Zentalis Pharmaceuticals, Inc.

Holdings reported by Ingmar Bruns for Zentalis Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 36,629 $83,617 $2.28 06 Feb 2025 Direct
Stock Option (Right to Buy) 16,629 03 Feb 2025 Direct Common Stock

Transactions reported by Ingmar Bruns for Zentalis Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.